Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitonin added to ropivacaine for erector spinae block in lumbar fusion surgery
IRCT20230204057318N8Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in postoperative pain comparing Calcitonin group with Plain ropivacaine group (2 arms). Primary endpoint: Time to first dose of rescue analgesic. Started Apr 2025; status: completed.
02
Drugs
TBRIAropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20230204057318N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230204057318N8.